SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

OneSource Specialty Pharma informs about board meeting

19 Jan 2026 Evaluate

In terms of SEBI Listing Regulations, OneSource Specialty Pharma has informed that a meeting of Board of Directors is scheduled to be held on Friday, January 23, 2026, to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended December 31,2025, amongst other matters. Further, as per the provisions of the Company’s Code of Conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for the Designated Persons of the Company, for the quarter ended December 31, 2025, is closed from January 01, 2026 and shall open after 48 hours after the dissemination of the financial results by the Company.

The above information is a part of company’s filings submitted to BSE.

Onesource Specialty Share Price

1821.55 -15.95 (-0.87%)
05-Jun-2026 09:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.70
Dr. Reddys Lab 1276.50
Cipla 1389.50
Zydus Lifesciences 1087.35
Lupin 2284.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×